A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2004
11/17/2004	EP1392713A4 Liver x receptor agonists
11/17/2004	EP1362045B1 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/17/2004	EP1311508B1 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004	EP1252322B1 Herpes virus strains for gene therapy
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1171120A4 Methods for alleviating discomfort of a hot flash and compositions therefor
11/17/2004	EP1159457A4 T cell receptor vbeta beta-jbeta) sequence and methods for its detection
11/17/2004	EP1154803B1 Immobilized labeling compounds and methods
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP1087762B1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
11/17/2004	EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines
11/17/2004	EP1075471B1 Indolyl derivatives as serotonergic agents
11/17/2004	EP0942732B1 Use of nk-1 receptor antagonists for treating movement disorders
11/17/2004	EP0942731B1 Use of nk-1 receptor antagonists for treating substance use disorders
11/17/2004	EP0923569B1 Butyric acid matrix metalloproteinase inhibitors
11/17/2004	EP0907658B1 Neuropeptide y agonists
11/17/2004	EP0904093A4 Administration of polypeptide growth factors following central nervous system ischemia or trauma
11/17/2004	EP0832092B1 Orally active adenosine kinase inhibitors
11/17/2004	EP0731811B1 Chaperonin 10
11/17/2004	CN1547672A Ultrasonic doppler effect speed measurement
11/17/2004	CN1547584A Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methods
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547581A 二氮杂萘衍生物 Naphthyridine derivatives
11/17/2004	CN1547580A CCR5 antagonists useful for treating aids
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547575A Novel phenylalkyl diamine and amide analogs
11/17/2004	CN1547570A Substituted c-cyclohexylmethylamine derivatives
11/17/2004	CN1547483A New use of ARTEMIN, a member of the GDNF ligand family
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547479A Pharmaceutical combination prepared by cannabis extract
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1547470A Use of phenyl pyridinyl methylaminomethyl piperidinyl methanone derivatives in the treatment of opioid dependence
11/17/2004	CN1547466A Extended release oral dosage form
11/17/2004	CN1547464A Prolonged release bioadhesive therapeutic systems
11/17/2004	CN1546491A Pteridine derivatives with nitric oxide synthase inhibitor function
11/17/2004	CN1546490A Asymmetric dihydroxyltropine alkaloids , their preparing process and pharmaceutical use
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1546136A Baras camphor, chuanxiong rhizome headache treating medicine and its oral preparation and its preparing process
11/17/2004	CN1546120A Chinese traditional medicine for treating peripheral facial paralysis
11/17/2004	CN1546116A Chinese traditional medicinal composition for treating hemicrania and its preparing process
11/17/2004	CN1546112A Application of Compound Danshen tablet in the preparation of medicine for preventing and treating senile dementia
11/17/2004	CN1546111A Application of Naoxinqing Tablet in the preparation of medicine for preventing and treating nerve function retrograde affection
11/17/2004	CN1546107A Analgesic
11/17/2004	CN1546096A Beautifying sleep-improving health tea
11/17/2004	CN1546063A Encephalic proteolytic products of compound Piracetam and its preparation
11/17/2004	CN1546038A Highly effective non-addictive analgesia for controlling megalgia as substitution of morphine series
11/17/2004	CN1546037A Diazepam dripping pills and its preparation process
11/17/2004	CN1546036A Nitrazepam dripping pills and its preparation process
11/17/2004	CN1546035A Lorazepam dripping pills and its preparation process
11/17/2004	CN1546022A Dripping pills of luteanine hydrochloride and its preparation
11/17/2004	CN1546014A Persimmon leaf extract and its preparation and its usage
11/17/2004	CN1176066C 1,1-and 1,2-disubsitituted cyclopropane compounds, preparation method thereof and drug compositions containing the same
11/17/2004	CN1175865C Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
11/17/2004	CN1175861C Analgesic and its preparation
11/17/2004	CN1175857C Medicine for preventing and treating cerebrovascular dementia
11/17/2004	CN1175855C Chinese traditional medicine for treating intractable headache and dizziness and its preparation process
11/17/2004	CN1175838C Brain-invigorating tic-stopping medicine and its prepn.
11/17/2004	CN1175819C Application of hydrochloric acid in preparing medicine for tumor
11/17/2004	CN1175814C Slow-releasing maclobemide tablet
11/17/2004	CN1175813C Donepezil hydrochloride dripping pills
11/17/2004	CN1175811C Slow-releasing Anixitan tablet
11/16/2004	US6818774 2-(s)-(6-(4-fluoro-benzyloxy)-3-oxo-3,4-dihydro-1h-isoquinolin -2-yl)- propionamide for example; alzheimer's disease or senile dementia
11/16/2004	US6818758 Estrogen receptor beta variants and methods of detection thereof
11/16/2004	US6818658 Treating obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction.
11/16/2004	US6818655 2-aminoquinolines; cardiovascular, gastrointestinal, pyschological, respiratory and nervous system disorders
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818648 Psychological disorders; anxiolytic agents; antidepressants; eating disorders; alcoholism; drug abuse; antiinflammatory agents
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818637 For use as antidiabetic agent
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818623 Active hedgehog protein conjugate
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/16/2004	US6818419 IRAK-4: compositions and methods of use
11/16/2004	CA2247164C Oxa- and thia-diazole muscarinic receptor antagonists
11/11/2004	WO2004097320A2 Thermal energy storage
11/11/2004	WO2004096845A2 Beta-amyloid inhibitors and use thereof
11/11/2004	WO2004096812A1 Fused pyrimidine derivative
11/11/2004	WO2004096808A1 Triazine compounds and their use
11/11/2004	WO2004096784A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1).
11/11/2004	WO2004096781A1 Use of derivatives of 2, 4-dihydro-[1,2,4]triazole-3-thione as inhibitors o fteh enzyme myeloperoxidase (mpo)
11/11/2004	WO2004096780A1 Quinoxalinone-3- one derivatives as orexin receptor antagonists
11/11/2004	WO2004096779A1 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having parp enzyme inhibitory effect
11/11/2004	WO2004096773A1 Quinolone derivatives
11/11/2004	WO2004096767A1 Sustituted indoline and indole derivatives
11/11/2004	WO2004096761A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/11/2004	WO2004096269A2 Botulinum neurotoxin for treating tics and obsessive compulsive behaviors
11/11/2004	WO2004096245A2 Muscle derived cells (mdcs) for promoting and enhancing nerve repair and regeneration
11/11/2004	WO2004096231A2 Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns
11/11/2004	WO2004096225A2 Use of tyrosine kinase inhibitors for treating cerebral ischemia
11/11/2004	WO2004096217A1 Use of n-type calcium channel inhibitors in treating demyelinating diseases
11/11/2004	WO2004096216A2 Use of a topical medicament comprising riluzole
11/11/2004	WO2004096209A1 The use of azetidinecarboxamide derivatives in therapy
11/11/2004	WO2004096208A1 Composition for oral administration containing alkylene dioxybenzene derivative
11/11/2004	WO2004096200A1 Combination of desoxypeganine and mecamylamine for the treatment of alcohol abuse
11/11/2004	WO2004096199A2 Regulation of guanine nucleotide exchange factor

1 ... 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 ... 1833